Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Neurofilament light chain… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Neurofilament light chain as a biomarker in neurological disorders

Artikel i vetenskaplig tidskrift
Författare L. Gaetani
Kaj Blennow
P. Calabresi
M. Di Filippo
L. Parnetti
Henrik Zetterberg
Publicerad i Journal of Neurology Neurosurgery and Psychiatry
Volym 90
Nummer/häfte 8
Sidor 870-881
ISSN 0022-3050
Publiceringsår 2019
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Sidor 870-881
Språk en
Länkar dx.doi.org/10.1136/jnnp-2018-320106
Ämnesord multiple sclerosis, dementia, motor neuron disease, Parkinson's disease, traumatic brain injury, cerebrospinal-fluid biomarkers, serum neurofilament, differential-diagnosis, multiple-sclerosis, csf, disease, protein, progression, disability, marker, Neurosciences & Neurology, Psychiatry, Surgery
Ämneskategorier Neurovetenskaper

Sammanfattning

In the management of neurological diseases, the identification and quantification of axonal damage could allow for the improvement of diagnostic accuracy and prognostic assessment. Neurofilament light chain (NfL) is a neuronal cytoplasmic protein highly expressed in large calibre myelinated axons. Its levels increase in cerebrospinal fluid (CSF) and blood proportionally to the degree of axonal damage in a variety of neurological disorders, including inflammatory, neurodegenerative, traumatic and cerebrovascular diseases. New immunoassays able to detect biomarkers at ultralow levels have allowed for the measurement of NfL in blood, thus making it possible to easily and repeatedly measure NfL for monitoring diseases' courses. Evidence that both CSF and blood NfL may serve as diagnostic, prognostic and monitoring biomarkers in neurological diseases is progressively increasing, and NfL is one of the most promising biomarkers to be used in clinical and research setting in the next future. Here we review the most important results on CSF and blood NfL and we discuss its potential applications and future directions.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?